Gimsilumab is under investigation in clinical trial NCT01357759 (Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.